BCG Vaccine and Fever in Newborns
Yes, BCG vaccine can cause fever in newborns, though high-grade fever (≥103°F/39°C) is uncommon and may signal serious complications requiring immediate medical attention.
Expected Post-Vaccination Reactions
The FDA drug label clearly states that patients may experience "flu-like" symptoms for 24-48 hours following BCG vaccination 1. This represents a normal, self-limited response to the live attenuated vaccine.
Normal vs. Concerning Fever
Low-grade fever and flu-like symptoms within the first 48 hours are expected and benign. However, the clinical picture changes dramatically with high-grade fever:
- Fever ≥103°F (39°C) requires immediate physician consultation 1
- High fever occurs in approximately 3.5% of vaccinated patients 2
- This level of fever may indicate:
- Severe disseminated mycobacterial infection (high mortality)
- Gram-negative bacterial sepsis
- Hypersensitivity reaction to BCG
The challenge is that these three conditions cannot be rapidly distinguished from each other, necessitating aggressive empirical treatment 2.
Timeline and Clinical Presentation
Typical Local Reactions (Not Fever-Related)
- Small red papules appear at vaccination site within 10-14 days
- Papules reach maximum diameter (~3mm) at 4-6 weeks
- May ulcerate and heal over 3 months 1
Serious Complications with Fever
When fever develops, particularly persistent or high-grade fever, consider:
Disseminated BCG infection - Most serious complication:
- Presents with persistent fever, skin rash, and respiratory symptoms
- Can occur 22-34 days post-vaccination 3
- May manifest as pneumonia, lymphadenopathy, hepatosplenomegaly 4, 5
- Mortality rate in preterm infants: 100%; in full-term infants: 28.6% 6
- Most deaths occur within one day of symptom onset 6
Critical Risk Factors
BCG is contraindicated in immunocompromised infants 7, 1. The vaccine should NOT be given to those with:
- HIV infection
- Congenital immunodeficiency (e.g., chronic granulomatous disease, SCID, CD3D deficiency)
- Severe combined immunodeficiency
- Immunosuppression from medications
Important Caveat
Even "healthy" infants without known immunodeficiency can develop disseminated BCG infection due to immature immune systems 3. Cases have been reported in infants with normal T-cell and neutrophil levels who later were diagnosed with underlying immunodeficiency only after developing disseminated BCG infection 4, 5.
Management Algorithm
For any fever post-BCG vaccination:
Low-grade fever <103°F for <48 hours:
- Reassure parents this is expected
- Supportive care
- Monitor for progression
Fever ≥103°F or persistent fever >48 hours:
- Immediate medical evaluation required 1
- Cannot distinguish between disseminated BCG, bacterial sepsis, or hypersensitivity clinically
- Requires aggressive empirical treatment
- Obtain mycobacterial cultures (though results take weeks)
- Consider anti-tuberculous therapy: rifampicin + isoniazid ± ethambutol ± streptomycin 4
- Evaluate for underlying immunodeficiency 4, 5
If disseminated BCG confirmed:
Prevention Strategies
- Screen for family history of immunodeficiency before BCG administration 4
- In families with known CGD or other immunodeficiencies, delay BCG until immunologic testing completed
- For infants <30 days of age, use half the standard dose 7
- All adverse reactions should be reported to VAERS 7
Key Clinical Pearls
- While BCG has excellent safety for the vast majority of newborns 6, serious complications, though rare, carry significant mortality
- Disseminated infection can present months after vaccination 2, so maintain high index of suspicion
- The presence of fever distinguishes potentially serious complications from expected local reactions
- When in doubt with high fever, treat aggressively - the mortality of untreated disseminated BCG infection far outweighs risks of empirical therapy 2, 6